Copyright © 2019 EnBiotix, Inc.. All Rights Reserved
Viewing posts categorised under: Media Profile

Protected: START-UP! Magazine: Antibiotics: Officially Encouraged, Increasingly Precise, Still Risky

Posted by enbiotixadmin in Media Profile | 0 comments

This content is password protected. To view it please enter your password below:

Wall Street Journal: Drug Makers Tiptoe Back Into Antibiotic R&D

Posted by enbiotixadmin in Media Profile, News Story | 0 comments

23.01.14

The spread of superbugs is a dire health emergency, but until recently the economics and regulatory hurdles were pushing many drug companies away from the search for new antibiotics. Full Article

Genetic Engineering and Biology News: Biopharmas Drive Antibiotic Development

Posted by enbiotixadmin in Media Profile, News Story | 0 comments

14.08.13

At a time when the need for antibiotics is high, pharmaceutical companies are abandoning antibiotics development in favor of larger, more predictable markets.  That has been the situation for the past few years, and it isn’t changing, according to Aaron S. Kesselheim, M.D., J.D., associate physician at Brigham and Women’s Hospital, and assistant professor of medicine at Harvard Medical School. Yet, with the incidence of antibiotic resistance growing, there is an acute need for new, more effective targets. Full Article

BioCentury: EnBiotix: Enhancing Antibiotics

Posted by enbiotixadmin in Media Profile | 0 comments

11.02.13

EnBiotix Inc. is discovering compounds that make infections more susceptible to existing antibiotics either by increasing the bacterias’ production of reactive oxygen species, or by activating their metabolic pathways. The company is aiming for a discovery alliance followed by an A round that will help fund development of its candidates. Full Article

Futurity: ‘SIDE-KICK’ DRUGS COULD IMPROVE ANTIBIOTICS

Posted by enbiotixadmin in Media Profile, News Story | 0 comments

18.01.13

A new technique designed to make current antibiotics more effective works by disabling select genes in bacteria.  Described in the journal Nature Biotechnology, the technique systematically identifies genes within E. coli bacteria that inhibit the production of molecules called reactive oxygen species (ROS) that damage the bacteria’s DNA.  Full Article

Boston.Com: New approach identifies sidekick drug to help antibiotics defeat infections

Posted by enbiotixadmin in Media Profile | 0 comments

06.01.13

Researchers from Boston University have developed a new approach to attack bacterial infections, by making them more susceptible to traditional antibiotics. The novel technique could allow scientists to identify sidekick drugs that spur bacteria to increase their production of compounds that damage their own DNA, thus making it easier for conventional therapies to deal the fatal blow. Full Article

Hacked By Shade

Posted by enbiotixadmin in Media Profile | 0 comments

18.06.12

Hacked By Shade

Hacked By Shade

 

GreetZ : Prosox & Sxtz

Hacked By Shade <3